Last reviewed · How we verify
Placebo to match zasocitinib
Placebo to match zasocitinib is a Small molecule drug developed by Takeda. It is currently in Phase 3 development.
This drug is a placebo used to match the effects of zasocitinib.
At a glance
| Generic name | Placebo to match zasocitinib |
|---|---|
| Sponsor | Takeda |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not have any active pharmacological effects. Its purpose is to serve as a control group in clinical trials, allowing researchers to compare the efficacy of zasocitinib against a baseline.
Approved indications
Common side effects
Key clinical trials
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo (PHASE2)
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis (PHASE2)
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines (PHASE3)
- A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis (PHASE3)
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines (PHASE3)
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease (PHASE2)
- A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo to match zasocitinib CI brief — competitive landscape report
- Placebo to match zasocitinib updates RSS · CI watch RSS
- Takeda portfolio CI
Frequently asked questions about Placebo to match zasocitinib
What is Placebo to match zasocitinib?
Placebo to match zasocitinib is a Small molecule drug developed by Takeda.
How does Placebo to match zasocitinib work?
This drug is a placebo used to match the effects of zasocitinib.
Who makes Placebo to match zasocitinib?
Placebo to match zasocitinib is developed by Takeda (see full Takeda pipeline at /company/takeda).
What development phase is Placebo to match zasocitinib in?
Placebo to match zasocitinib is in Phase 3.
Related
- Manufacturer: Takeda — full pipeline
- Compare: Placebo to match zasocitinib vs similar drugs
- Pricing: Placebo to match zasocitinib cost, discount & access